Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan;43(1):90-124.
doi: 10.1002/jimd.12126. Epub 2019 Jun 25.

CDG and immune response: From bedside to bench and back

Carlota Pascoal  1   2   3 , Rita Francisco  1   2   3 , Tiago Ferro  2   3 , Vanessa Dos Reis Ferreira  1   2 , Jaak Jaeken  2   4 , Paula A Videira  1   2   3
Affiliations
Review

CDG and immune response: From bedside to bench and back

Carlota Pascoal et al. J Inherit Metab Dis. 2020 Jan.

Abstract

Glycosylation is an essential biological process that adds structural and functional diversity to cells and molecules, participating in physiological processes such as immunity. The immune response is driven and modulated by protein-attached glycans that mediate cell-cell interactions, pathogen recognition and cell activation. Therefore, abnormal glycosylation can be associated with deranged immune responses. Within human diseases presenting immunological defects are congenital disorders of glycosylation (CDG), a family of around 130 rare and complex genetic diseases. In this review, we have identified 23 CDG with immunological involvement, characterized by an increased propensity to-often life-threatening-infection. Inflammatory and autoimmune complications were found in 7 CDG types. CDG natural history(ies) and the mechanisms behind the immunological anomalies are still poorly understood. However, in some cases, alterations in pathogen recognition and intracellular signaling (eg, TGF-β1, NFAT, and NF-κB) have been suggested. Targeted therapies to restore immune defects are only available for PGM3-CDG and SLC35C1-CDG. Fostering research on glycoimmunology may elucidate the involved pathophysiological mechanisms and open new therapeutic avenues, thus improving CDG patients' quality of life.

Keywords: autoimmune disease; congenital disorders of glycosylation; immune system; immunodeficiency; infection; inflammation.

PubMed Disclaimer

References

REFERENCES

    1. An HJ, Froehlich JW, Lebrilla CB. Determination of glycosylation sites and site-specific heterogeneity in glycoproteins. Curr Opin Chem Biol. 2009;13:421-426.
    1. Jensen PH, Karlsson NG, Kolarich D, Packer NH. Structural analysis of N- and O-glycans released from glycoproteins. Nat Protoc. 2012;7:1299-1310.
    1. Mitra N, Sharon N, Surolia A. Role of N-linked glycan in the unfolding pathway of Erythrina corallodendron lectin. Biochemistry. 2003;42(42):12208-12216. https://doi.org/10.1021/BI035169E.
    1. Piller F, Piller V, Fox RI, Fukuda M. Human T-lymphocyte activation is associated with changes in O-glycan biosynthesis. J Biol Chem. 1988;263:15146-15150.
    1. Hebert DN, Garman SC, Molinari M. The glycan code of the endoplasmic reticulum: asparagine-linked carbohydrates as protein maturation and quality-control tags. Trends Cell Biol. 2005;15:364-370.

Publication types

MeSH terms